Cristin Rothfuss

General Counsel, Sarepta Therapeutics.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 4, 2026Shares withheld for tax 22,025 shares at $22.22 of Sarepta Therapeutics²
Mar 11, 2026Shares withheld for tax 974 shares at $17.03 of Sarepta Therapeutics³
Mar 9, 2026Shares withheld for tax 346 shares at $16.95 of Sarepta Therapeutics⁴
Mar 9, 2026Shares withheld for tax 484 shares at $16.95 of Sarepta Therapeutics⁴
Mar 2, 2026Shares withheld for tax 408 shares at $16.20 of Sarepta Therapeutics⁵
Nov 28, 2025Shares withheld for tax 229 shares at $21.12 of Sarepta Therapeutics⁶
Sep 3, 2025Granted 25,000 shares of Sarepta Therapeutics⁷
Sep 3, 2025Granted 93,875 shares of Sarepta Therapeutics⁷
Mar 10, 2025Granted 8,276 shares of Sarepta Therapeutics⁸
Mar 10, 2025Shares withheld for tax 491 shares at $100.13 of Sarepta Therapeutics⁸
Mar 7, 2025Shares withheld for tax 347 shares at $103.70 of Sarepta Therapeutics⁹
Mar 7, 2025Shares withheld for tax 1,131 shares at $103.70 of Sarepta Therapeutics⁹
Mar 4, 2025Shares withheld for tax 296 shares at $101.34 of Sarepta Therapeutics¹⁰
Mar 4, 2025Shares withheld for tax 288 shares at $101.34 of Sarepta Therapeutics¹⁰
Mar 3, 2025Shares withheld for tax 391 shares at $103.77 of Sarepta Therapeutics¹¹
Nov 26, 2024Granted 2,000 shares of Sarepta Therapeutics¹²

The numbers on this page point here. Each one links to the record it came from.